CRSP: CRISPR Therapeutics AG Stock

by  •  • Comments Off on CRSP: CRISPR Therapeutics AG Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,118.57
Enterprise Value ($M) 2,820.32
Book Value ($M) 1,932.08
Book Value / Share 22.37
Price / Book 1.61
NCAV ($M) 1,627.18
NCAV / Share 18.84
Price / NCAV 1.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.18
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 22.07
Current Ratio 22.07

Balance Sheet (mrq) ($M)
Current Assets 1,937.13
Assets 2,242.03
Liabilities 309.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.31
Operating Income -466.57
Net Income -366.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -142.77
Cash from Investing -280.48
Cash from Financing 331.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A ARK Investment Management LLC 10.51
2024-04-10 13G/A Capital International Investors 10.20 28.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 674,070 2,245,527 30.02
2025-05-07 704,071 2,911,722 24.18
2025-05-06 1,156,488 3,639,225 31.78
2025-05-05 354,022 1,153,802 30.68

(click for more detail)

Similar Companies
CLYM – Climb Bio, Inc. CRMD – CorMedix Inc.
CRON – Cronos Group Inc. CRVS – Corvus Pharmaceuticals, Inc.
CURR – CURRENC Group Inc.


Financial data and stock pages provided by
Fintel.io